Cleared Traditional

K073130 - SPY FLUORESCENT IMAGING SYSTEM

K073130 is an FDA 510(k) clearance for SPY FLUORESCENT IMAGING SYSTEM, manufactured by Novadaq Technologies, Inc.. The device is a Class 2 Radiology device with product code IZI cleared through the Traditional 510(k) pathway after a 65-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2008
Decision
65d
Days
Class 2
Risk

K073130 is an FDA 510(k) clearance for the SPY FLUORESCENT IMAGING SYSTEM. Classified as System, X-ray, Angiographic (product code IZI), Class II - Special Controls.

Submitted by Novadaq Technologies, Inc. (Mississauga, Ontario, CA). The FDA issued a Cleared decision on January 10, 2008 after a review of 65 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1600 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Novadaq Technologies, Inc. devices

FDA 510(k) Submission Details - K073130

510(k) Number K073130 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 06, 2007
Decision Date January 10, 2008
Days to Decision 65 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
42d faster than avg
Panel avg: 107d · This submission: 65d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

IZI Device Classification - Class 2, Special Controls

Product Code IZI System, X-ray, Angiographic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1600
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - IZI System, X-ray, Angiographic

All 102
Devices cleared under the same product code (IZI) and FDA review panel - the closest regulatory comparables to K073130.
INTEGRATED INNOVA - S5I SYSTEM OPTION
K111209 · Ge Healthcare · Jul 2011
ARTIS ZEE / ZEEGOS WITH SW VC14
K090745 · Siemens Medical Solutions USA, Inc. · Jun 2009
ARTIS ZEE AND ZEEGO
K073290 · Siemens Medical Solutions USA, Inc. · Feb 2008
DAR-9400F
K072006 · Shimadzu Corp. · Aug 2007
GE OEC ALTITUDE
K071717 · Shimadzu Corp. · Jul 2007
BRANSIST SAFIRE
K062360 · Shimadzu Corp. · Oct 2006